Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 03:43:55 GMT 2025
by
admin
on
Wed Apr 02 03:43:55 GMT 2025
|
| Protein Type | FC FUSION PROTEIN |
| Protein Sub Type | INTERLEUKINS |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
ZQ9E6EX2JE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C26170
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
||
|
FDA ORPHAN DRUG |
581117
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11233
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
PRIMARY | |||
|
C141419
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
PRIMARY | |||
|
2200269-84-5
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
PRIMARY | |||
|
1966971-51-6
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
NO STRUCTURE GIVEN | |||
|
300000019951
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
PRIMARY | |||
|
ZQ9E6EX2JE
Created by
admin on Wed Apr 02 03:43:55 GMT 2025 , Edited by admin on Wed Apr 02 03:43:55 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_7 | 1_99 |
| 1_56 | 1_145 |
| 1_165 | 2_165 |
| 1_168 | 2_168 |
| 1_199 | 1_259 |
| 1_305 | 1_363 |
| 2_7 | 2_99 |
| 2_56 | 2_145 |
| 2_199 | 2_259 |
| 2_305 | 2_363 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_21 |
| N | 1_35 |
| N | 1_64 |
| N | 1_235 |
| N | 2_21 |
| N | 2_35 |
| N | 2_64 |
| N | 2_235 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID REMOVAL | [1_385] [2_385] | C-TERMINUS | LYSINE | K3Z4F929H6 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|